1802086-25-4 | Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt H-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH trifluoroacetate salt
Pack Size
Purity
Availability
Price(USD)
Quantity
1mg
99%
1 week
$447.00
$313.00
-+
5mg
99%
1 week
$1,241.00
$869.00
-+
10mg
99%
1 week
$1,955.00
$1,369.00
-+
Technical Information
Properties
Literature
Request for Quotation
Download SDS
Technical Information
Properties
Literature
Technical Information
Catalog Number:
AA01E6V9
Chemical Name:
Gastric Inhibitory Polypeptide (3-42) (human) trifluoroacetate salt H-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH trifluoroacetate salt
CAS Number:
1802086-25-4
MDL Number:
MFCD18782440
Properties
Literature
Title: V A Gault, et al. Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo. J Endocrinol. 2002 Nov;175(2):525-33.